Literature DB >> 33559024

Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity.

Anna Hernández-Aguilera1, Núria Casacuberta2, Helena Castañé1, Montserrat Fibla1, Salvador Fernández-Arroyo1, Isabel Fort-Gallifa2, Marta París3, Fàtima Sabench3, Daniel Del Castillo3, Gerard Baiges-Gaya1, Elisabet Rodríguez-Tomàs1, Teresa Sans2, Jordi Camps4, Jorge Joven1.   

Abstract

Nonalcoholic steatohepatitis (NASH) is frequently associated with severe obesity. The liver is the principal storage repository for iron, and the excessive accumulation of this metal may promote hepatic inflammation. Laparoscopic sleeve gastrectomy (LSG) results in weight loss and improvement in comorbidities such as NASH. The aim of this study was to assess the specific NASH-related changes in iron metabolism and to investigate whether these changes are reversed by LSG. We included 150 patients with morbid obesity who provided 12-h fasting blood samples immediately before LSG together with an intraoperative wedge-liver biopsy. Thirty-eight patients with NASH underwent a second blood extraction 12 months postsurgery. Serum samples were collected from a control group comprising 50 healthy volunteers. We found significantly higher serum iron and transferrin concentrations in patients with NASH along with the highest degrees of steatosis, fibrosis, hepatocellular ballooning, and lobular inflammation. However, we did not find any significant accumulation of iron in the hepatic biopsies. Presurgery serum iron concentrations were lower in the patient group than in the control group and increased 1 year postsurgery. Serum ferritin levels showed changes in the opposite direction. We did not observe any significant change in serum transferrin concentrations. These changes were reversed by LSG. We conclude that alterations in serum iron-related variables are related to the severity of NASH in patients with morbid obesity, and these alterations are reversed by LSG. We also found that severe forms of NASH can be found in the absence of increased iron stores.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Bariatric surgery; Iron; Nonalcoholic steatohepatitis; Obesity

Mesh:

Substances:

Year:  2021        PMID: 33559024     DOI: 10.1007/s12011-021-02610-8

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  35 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

Review 2.  Overview of iron metabolism in health and disease.

Authors:  Som Dev; Jodie L Babitt
Journal:  Hemodial Int       Date:  2017-03-15       Impact factor: 1.812

3.  Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.

Authors:  Noemí Cabré; Fedra Luciano-Mateo; Salvador Fernández-Arroyo; Gerard Baiges-Gayà; Anna Hernández-Aguilera; Montserrat Fibla; Raul Fernández-Julià; Marta París; Fàtima Sabench; Daniel Del Castillo; Javier A Menéndez; Jordi Camps; Jorge Joven
Journal:  Metabolism       Date:  2019-07-04       Impact factor: 8.694

Review 4.  Transferrin: structure, function and potential therapeutic actions.

Authors:  Peter T Gomme; Karl B McCann; Joseph Bertolini
Journal:  Drug Discov Today       Date:  2005-02-15       Impact factor: 7.851

Review 5.  A systems biology approach to iron metabolism.

Authors:  Julia Chifman; Reinhard Laubenbacher; Suzy V Torti
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis.

Authors:  Diana Moya; Susan S Baker; Wensheng Liu; Michael Garrick; Rafal Kozielski; Robert D Baker; Lixin Zhu
Journal:  Clin Nutr       Date:  2014-06-24       Impact factor: 7.324

Review 7.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

8.  Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity.

Authors:  Xiaoya Li; Tian-Xiang Wang; Xinmei Huang; Yue Li; Tiange Sun; Shufei Zang; Kun-Liang Guan; Yue Xiong; Jun Liu; Hai-Xin Yuan
Journal:  Liver Int       Date:  2020-03-20       Impact factor: 5.828

Review 9.  Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration.

Authors:  Barry B Muhoberac; Ruben Vidal
Journal:  Front Neurosci       Date:  2019-12-11       Impact factor: 4.677

View more
  1 in total

1.  Iron Deficiency and Anemia 10 Years After Roux-en-Y Gastric Bypass for Severe Obesity.

Authors:  Jorunn Sandvik; Kirsti Kverndokk Bjerkan; Hallvard Græslie; Dag Arne Lihaug Hoff; Gjermund Johnsen; Christian Klöckner; Ronald Mårvik; Siren Nymo; Åsne Ask Hyldmo; Bård Eirik Kulseng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-22       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.